GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Net Interest Income

Remus Pharmaceuticals (NSE:REMUS) Net Interest Income : ₹11 Mil (TTM As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Remus Pharmaceuticals Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Remus Pharmaceuticals's net interest income for the six months ended in Sep. 2024 was ₹-7 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was ₹11 Mil.

Remus Pharmaceuticals Net Interest Income Historical Data

The historical data trend for Remus Pharmaceuticals's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remus Pharmaceuticals Net Interest Income Chart

Remus Pharmaceuticals Annual Data
Trend Mar20 Mar21 Mar22 Mar24
Net Interest Income
-0.43 0.32 1.56 17.50

Remus Pharmaceuticals Semi-Annual Data
Mar20 Mar21 Mar22 Sep23 Mar24 Sep24
Net Interest Income Get a 7-Day Free Trial - - -0.95 18.45 -7.24

Remus Pharmaceuticals Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Remus Pharmaceuticals Net Interest Income Related Terms

Thank you for viewing the detailed overview of Remus Pharmaceuticals's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Remus Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Remus Pharmaceuticals Ltd (NSE:REMUS) » Definitions » Net Interest Income
Comparable Companies
NSE:DENTALKART BOM:544353 BOM:544143 BOM:536565 BOM:530697 BOM:543500 BOM:523896 BOM:531240 MCK COR CAH ASX:SIG SHSE:601607 HSIC HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO TSE:7459
Traded in Other Exchanges
N/A
Address
Ambli bopal Road, 1101 to 1103, South Tower, One 42, Behind Ashok Vatika, Near Jayantilal Park BRTS, Ahmedabad, GJ, IND, 380054
Website
https://www.remuspharma.com
Remus Pharmaceuticals Ltd is engaged in the marketing & distribution of finished formulations of pharmaceutical drugs. The company also deals in API (Active Pharmaceutical Ingredient). It also provides technical consultancy services to various distributors for the preparation of reports on the dossiers of the products to be registered by them in various countries. Remus Pharmaceuticals market niche medicinal combinations. It exports generic drugs by conducting intensive market research in the pharmaceutical industry to expand its product portfolio.

Remus Pharmaceuticals Headlines

No Headlines